Stimulation of proliferation in the colorectal mucosa by gastrin precursors is blocked by desferrioxamine

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 299, Issue 1, 2010, Pages

  Ferrand, Audrey ^a   Lachal, Shamilah ^a   Bramante, Gianni ^a   Kovac, Suzana ^a   Shulkes, Arthur ^a   Baldwin, Graham S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Colon; Iron

Indexed keywords

DEFEROXAMINE; GLYCINE EXTENDED GASTRIN; HORMONE PRECURSOR; PROGASTRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; CELL PROLIFERATION; COLON MUCOSA; COLORECTAL CARCINOMA; COLOSTOMY; CONTROLLED STUDY; FEMALE; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RECTUM MUCOSA; WILD TYPE;

ANIMALS; CELL PROLIFERATION; COLON; COLOSTOMY; DEFEROXAMINE; FEMALE; GASTRINS; HUMANS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, INTRAPERITONEAL; INTESTINAL MUCOSA; IRON; MALE; MICE; MICE, TRANSGENIC; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; RECTUM; SIDEROPHORES; TIME FACTORS;

EID: 77954378961     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00046.2010     Document Type: Article

References (38)

1. Allen KJ, Gurrin LC, Constantine CC, Osborne NJ, Delatycki MB, Nicoll AJ, McLaren CE, Bahlo M, Nisselle AE, Vulpe CD, Anderson GJ, Southey MC, Giles GG, English DR, Hopper JL, Olynyk JK, Powell LW, Gertig DM. Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med 358: 221-230, 2008.
2. Aly A, Shulkes A, Baldwin GS. Short term infusion of glycine-extended gastrin(17) stimulates both proliferation and formation of aberrant crypt foci in rat colonic mucosa. Int J Cancer 94: 307-313, 2001. (Pubitemid 32906058)
3. Baldwin GS. Properties of the complex between recombinant human progastrin and ferric ions. Protein J 23: 65-70, 2004.
4. Baldwin GS, Curtain CC, Sawyer WH. Selective, high-affinity binding of ferric ions by glycine-extended gastrin(17). Biochemistry 40: 10741-10746, 2001.
5. Becton DL, Bryles P. Deferoxamine inhibition of human neuroblastoma viability and proliferation. Cancer Res 48: 7189-7192, 1988. (Pubitemid 19014003)
6. Blatt J. Deferoxamine in children with recurrent neuroblastoma. Anticancer Res 14: 2109-2112, 1994.
7. Blatt J, Stitely S. Antineuroblastoma activity of deferoxamine in human cell lines. Cancer Res 47: 1749-1750, 1987. (Pubitemid 17056669)
8. Brookes MJ, Hughes S, Turner FE, Reynolds G, Sharma N, Ismail T, Berx G, McKie AT, Hotchin N, Anderson GJ, Iqbal T, Tselepis C. Modulation of iron transport proteins in human colorectal carcinogenesis. Gut 55: 1449-1460, 2006.
9. Ciccotosto GD, McLeish A, Hardy KJ, Shulkes A. Expression, processing, and secretion of gastrin in patients with colorectal carcinoma. Gastroenterology 109: 1142-1153, 1995.
10. Cobb S, Wood T, Ceci J, Varro A, Velasco M, Singh P. Intestinal expression of mutant and wild-type progastrin significantly increases colon carcinogenesis in response to azoxymethane in transgenic mice. Cancer 100: 1311-1323, 2004.
11. Donfrancesco A, Deb G, Dominici C, Pileggi D, Castello MA, Helson L. Effects of a single course of deferoxamine in neuroblastoma patients. Cancer Res 50: 4929-4930, 1990.
12. Hollande F, Imdahl A, Mantamadiotis T, Ciccotosto GD, Shulkes A, Baldwin GS. Glycine-extended gastrin acts as an autocrine growth factor in a nontransformed colon cell line. Gastroenterology 113: 1576-1588, 1997.
13. Ilsley JN, Belinsky GS, Guda K, Zhang Q, Huang X, Blumberg JB, Milbury PE, Roberts LJ 2nd, Stevens RG, Rosenberg DW. Dietary iron promotes azoxymethane-induced colon tumors in mice. Nutr Cancer 49: 162-169, 2004.
14. Koh TJ, Dockray GJ, Varro A, Cahill RJ, Dangler CA, Fox JG, Wang TC. Overexpression of glycine-extended gastrin in transgenic mice results in increased colonic proliferation. J Clin Invest 103: 1119-1126, 1999.
15. Kubben FJ, Peeters-Haesevoets A, Engels LG, Baeten CG, Schutte B, Arends JW, Stockbrugger RW, Blijham GH. Proliferating cell nuclear antigen (PCNA): a new marker to study human colonic cell proliferation. Gut 35: 530-535, 1994. (Pubitemid 24131252)
16. Le NT, Richardson DR. The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochim Biophys Acta 1603: 31-46, 2002.
17. Nelson RL. Iron and colorectal cancer risk: human studies. Nutr Rev 59: 140-148, 2001.
18. Pannequin J, Barnham KJ, Hollande F, Shulkes A, Norton RS, Baldwin GS. Ferric ions are essential for the biological activity of the hormone glycine-extended gastrin. J Biol Chem 277: 48602-48609, 2002.
19. Pannequin J, Kovac S, Tantiongco JP, Norton RS, Shulkes A, Barnham KJ, Baldwin GS. A novel effect of bismuth ions: selective inhibition of the biological activity of glycine-extended gastrin. J Biol Chem 279: 2453-2460, 2004.
20. Pannequin J, Tantiongco JP, Kovac S, Shulkes A, Baldwin GS. Divergent roles for ferric ions in the biological activity of amidated and non-amidated gastrins. J Endocrinol 181: 315-325, 2004.
21. Prutki M, Poljak-Blazi M, Jakopovic M, Tomas D, Stipancic I, Zarkovic N. Altered iron metabolism, transferrin receptor 1 and ferritin in patients with colon cancer. Cancer Lett 238: 188-196, 2006. (Pubitemid 43867908)
22. Sakaida I, Hironaka K, Uchida K, Okita K. Iron chelator deferoxamine reduces preneoplastic lesions in liver induced by choline-deficient L-amino acid-defined diet in rats. Dig Dis Sci 44: 560-569, 1999. (Pubitemid 29137968)
23. Schaer JC, Reubi JC. High gastrin and cholecystokinin (CCK) gene expression in human neuronal, renal, and myogenic stem cell tumors: comparison with CCK-A and CCK-B receptor contents. J Clin Endocrinol Metab 84: 233-239, 1999.
24. Selig RA, White L, Gramacho C, Sterling-Levis K, Fraser IW, Naidoo D. Failure of iron chelators to reduce tumor growth in human neuroblastoma xenografts. Cancer Res 58: 473-478, 1998. (Pubitemid 28087409)
25. Shaheen NJ, Silverman LM, Keku T, Lawrence LB, Rohlfs EM, Martin CF, Galanko J, Sandler RS. Association between hemochromatosis (HFE) gene mutation carrier status and the risk of colon cancer. J Natl Cancer Inst 95: 154-159, 2003. (Pubitemid 36193264)
26. Siddheshwar RK, Gray JC, Kelly SB. Plasma levels of progastrin but not amidated gastrin or glycine extended gastrin are elevated in patients with colorectal carcinoma. Gut 48: 47-52, 2001.
27. Simonart T, Boelaert JR, Andrei G, Clercq ED, Snoeck R. Iron withdrawal strategies fail to prevent the growth of SiHa-induced tumors in mice. Gynecol Oncol 90: 91-95, 2003. (Pubitemid 37338081)
28. Simonart T, Boelaert JR, Andrei G, van den Oord JJ, Degraef C, Hermans P, Noel JC, Van Vooren JP, Heenen M, De Clercq E, Snoeck R. Desferrioxamine enhances AIDS-associated Kaposi's sarcoma tumor development in a xenograft model. Int J Cancer 100: 140-143, 2002.
29. Simonart T, Boelaert JR, Mosselmans R, Andrei G, Noel JC, De Clercq E, Snoeck R. Antiproliferative and apoptotic effects of iron chelators on human cervical carcinoma cells. Gynecol Oncol 85: 95-102, 2002.
30. Singh P, Velasco M, Given R, Varro A, Wang TC. Progastrin expression predisposes mice to colon carcinomas and adenomas in response to a chemical carcinogen. Gastroenterology 119: 162-171, 2000.
31. Smith AM, Justin T, Michaeli D, Watson SA. Phase I/II study of G17-DT, an anti-gastrin immunogen, in advanced colorectal cancer. Clin Cancer Res 6: 4719-4724, 2000.
32. Smith KA, Kovac S, Anderson GJ, Shulkes A, Baldwin GS. Circulating gastrin is increased in hemochromatosis. FEBS Lett 580: 6195-6198, 2006.
33. Stepan VM, Krametter DF, Matsushima M, Todisco A, Delvalle J, Dickinson CJ. Glycine-extended gastrin regulates HEK cell growth. Am J Physiol Regul Integr Comp Physiol 277: R572-R581, 1999.
34. Thorburn CM, Friedman GD, Dickinson CJ, Vogelman JH, Orentreich N, Parsonnet J. Gastrin and colorectal cancer: a prospective study. Gastroenterology 115: 275-280, 1998. (Pubitemid 28363419)
35. Van Solinge WW, Nielsen FC, Friis-Hansen L, Falkmer UG, Rehfeld JF. Expression but incomplete maturation of progastrin in colorectal carcinomas. Gastroenterology 104: 1099-1107, 1993. (Pubitemid 23090763)
36. Wang TC, Koh TJ, Varro A, Cahill RJ, Dangler CA, Fox JG, Dockray GJ. Processing and proliferative effects of human progastrin in transgenic mice. J Clin Invest 98: 1918-1929, 1996.
37. Weinberg ED. Cellular iron metabolism in health and disease. Drug Metab Rev 22: 531-579, 1990.
38. Yu Y, Wong J, Lovejoy DB, Kalinowski DS, Richardson DR. Chelators at the cancer coalface: desferrioxamine to Triapine and beyond. Clin Cancer Res 12: 6876-6883, 2006. (Pubitemid 44974479)